Does concurrent use of clopidogrel and PPIs increase CV risk in patients with ACS? | Zendy

AI Assistant Blog Pricing

Open Access

Does concurrent use of clopidogrel and PPIs increase CV risk in patients with ACS?

Author(s) -

Shehata

Publication year - 2020

Publication title -

the journal of family practice

Language(s) - English

DOI - 10.12788/jfp.0025

Subject(s) - medicine , clopidogrel , acute coronary syndrome , randomized controlled trial , myocardial infarction , aspirin , proton pump inhibitor , cardiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.